Docosahexaenoic acid (DHA), an omega-3 long chain polyunsaturated fatty acid, is the building block of brain tissue. It is the primary structural fatty acid in the gray matter of the brain and retina of the eye. DHA is an essential nutrient for eye development and for mental and visual function. Humans obtain DHA from their diets, initially through the placenta and from breast milk, but these levels are commonly low in pregnant and breast feeding women. DHA is commonly added to infant formula in Japan and Europe, but unfortunately has still not been added to US infant formulas. In addition, vegetarians eating no fish have very low to no DHA in their body. Benefits of DHA:
- Nervous System (eyes & brain) of Developing Fetus
- Growing Brain of Infant
- Healthy Heart/ Good HDL Cholesterol
- Brain Function
- Healthy Eyes
Each Softgel Contains:
- DHA (docosahexaenoic acid).......100 mg or 200mg (depending on size)
(Derived from an organic vegetable source cultivated under highly controlled conditions)
- High oleic sunflower oil.......400 mg
- vitamin E (as mixed tocopherols).......0.18 mg
- vitamin C (as ascorbyl palmitate).......0.125 mg
Recommendations
Pure Encapsulations recommends 100–200 mg per day, with a meal; 200 mg daily
is especially recommended for pregnant and lactating women.
Read Customer questions and answers about Pregnancy in our FAQ.
Uses For Neuromins™
Healthy Neural And Visual Development: Docosahexaenoic acid (DHA), an omega-3
long chain polyunsaturated fatty acid, is the building block of brain tissue. It
is the primary structural fatty acid in the gray matter of the brain and retina
of the eye. DHA is an essential nutrient for eye development and for mental and
visual function. Humans obtain DHA from their diets, initially through the
placenta and from breast milk. DHA is commonly added to infant formula in Japan
and Europe. Clinical trials of supplementation with Neuromins™ in healthy
vegetarians have shown an increase in serum DHA and EPA levels.
What Is It?
Neuromins™ is a vegetable source of docosahexaenoic acid (DHA), an essential
omega-3 fatty acid. While most DHA is obtained from fish oils, Neuromins™ is
extracted from microalgae, the fish's original food source, under tightly
controlled food manufacturing conditions.
Neuromins by Pure Encapsulations
Data Sheet pdf File
What Is The Source?
Pure Encapsulations Neuromins™ DHA is extracted from microalgae. Pure
Encapsulations Neuromins™ also contains vitamin C (ascorbyl palmitate) (corn
dextrose fermentation) and vitamin E (mixed tocopherols) (soy).
Are There Any Potential Side Effects Or Precautions?
At this time, there are no known side effects or precautions.
Are There Any Potential Drug Interactions?
At this time, there are no known adverse reactions when taken in conjunction
with medications.
References:
- Conquer JA, Holub BJ. Supplementation with an algae source of
docosahexaenoic acid increases (n-3) fatty acid status and alters selected
risk factors for heart disease in vegetarian subjects. J Nutr 1996
Dec;126(12):3032 3039.
- Jensen CL, Maude M, Anderson RE, Heird WC. Effect of docosahexaenoic acid
supplementation of lactating women on the fatty acid composition of breast
milk lipids and maternal and infant plasma phospholipids. Am J Clin Nutr 2000
Jan;71(1 Suppl):292S-9S.
- Treen M, Uauy RD, Jameson DM, Thomas VL, Hoffman DR. Effect of
docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79
retinoblastoma cells. Arch Biochem Biophys 1992 May 1;294(2):564-570.
- Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid
composition of brain, retina, and erythrocytes in breast and formula-fed
infants. Am J Clin Nutr 1994 Aug;60(2):189-194.
- Carlson SE, Werkman SH, Peeples JM, Wilson WM. Long-chain fatty acids and
early visual and cognitive development of preterm infants. Eur J Clin Nutr
1994 Aug;48 Suppl 2:S27-S30.
- Werkman SH; Carlson SE. A randomized trial of visual attention of preterm
infants fed docosahexaenoic acid until nine months. Lipids 1996
Jan;31(1):91-7.
- Healthnotes Clinical Essentials. Copyright 2003. Healthnotes, Inc.
|
|